810 related articles for article (PubMed ID: 16257063)
21. Toxicity of select beta adrenergic receptor-blocking pharmaceuticals (B-blockers) on aquatic organisms.
Huggett DB; Brooks BW; Peterson B; Foran CM; Schlenk D
Arch Environ Contam Toxicol; 2002 Aug; 43(2):229-35. PubMed ID: 12115049
[TBL] [Abstract][Full Text] [Related]
22. Carbamazepine and diclofenac: removal in wastewater treatment plants and occurrence in water bodies.
Zhang Y; Geissen SU; Gal C
Chemosphere; 2008 Nov; 73(8):1151-61. PubMed ID: 18793791
[TBL] [Abstract][Full Text] [Related]
23. [Pharmaceuticals as pollution].
Grung M; Langford K; Thomas KV
Tidsskr Nor Laegeforen; 2012 May; 132(10):1249-51. PubMed ID: 22669389
[TBL] [Abstract][Full Text] [Related]
24. Comparative physiology, pharmacology and toxicology of beta-blockers: mammals versus fish.
Owen SF; Giltrow E; Huggett DB; Hutchinson TH; Saye J; Winter MJ; Sumpter JP
Aquat Toxicol; 2007 May; 82(3):145-62. PubMed ID: 17382413
[TBL] [Abstract][Full Text] [Related]
25. Source to sink tracking of selected human pharmaceuticals from two Oslo city hospitals and a wastewater treatment works.
Thomas KV; Dye C; Schlabach M; Langford KH
J Environ Monit; 2007 Dec; 9(12):1410-8. PubMed ID: 18049781
[TBL] [Abstract][Full Text] [Related]
26. Assessment of the environmental fate and effects of ivermectin in aquatic mesocosms.
Sanderson H; Laird B; Pope L; Brain R; Wilson C; Johnson D; Bryning G; Peregrine AS; Boxall A; Solomon K
Aquat Toxicol; 2007 Dec; 85(4):229-40. PubMed ID: 17963854
[TBL] [Abstract][Full Text] [Related]
27. Physiological effects of diclofenac, ibuprofen and propranolol on Baltic Sea blue mussels.
Ericson H; Thorsén G; Kumblad L
Aquat Toxicol; 2010 Aug; 99(2):223-31. PubMed ID: 20554059
[TBL] [Abstract][Full Text] [Related]
28. Exposure assessment of the pharmaceutical diclofenac based on long-term measurements of the aquatic input.
Letzel M; Metzner G; Letzel T
Environ Int; 2009 Feb; 35(2):363-8. PubMed ID: 19027956
[TBL] [Abstract][Full Text] [Related]
29. Identification of the pharmaceuticals for human use contaminating the Italian aquatic environment.
Zuccato E; Castiglioni S; Fanelli R
J Hazard Mater; 2005 Jul; 122(3):205-9. PubMed ID: 15967275
[TBL] [Abstract][Full Text] [Related]
30. Highly active human pharmaceuticals in aquatic systems: A concept for their identification based on their mode of action.
Christen V; Hickmann S; Rechenberg B; Fent K
Aquat Toxicol; 2010 Feb; 96(3):167-81. PubMed ID: 20053463
[TBL] [Abstract][Full Text] [Related]
31. Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of Carbamazepine in wastewater treatment and during groundwater infiltration.
Clara M; Strenn B; Kreuzinger N
Water Res; 2004 Feb; 38(4):947-54. PubMed ID: 14769414
[TBL] [Abstract][Full Text] [Related]
32. Bioaccumulation and biomagnification potential of pharmaceuticals with a focus to the aquatic environment.
Zenker A; Cicero MR; Prestinaci F; Bottoni P; Carere M
J Environ Manage; 2014 Jan; 133():378-87. PubMed ID: 24419205
[TBL] [Abstract][Full Text] [Related]
33. Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters.
Lindqvist N; Tuhkanen T; Kronberg L
Water Res; 2005 Jun; 39(11):2219-28. PubMed ID: 15935437
[TBL] [Abstract][Full Text] [Related]
34. Do pharmaceuticals affect freshwater invertebrates? A study with the cnidarian Hydra vulgaris.
Pascoe D; Karntanut W; Müller CT
Chemosphere; 2003 May; 51(6):521-8. PubMed ID: 12615105
[TBL] [Abstract][Full Text] [Related]
35. Human pharmaceuticals in the aquatic environment: a review of recent toxicological studies and considerations for toxicity testing.
Brausch JM; Connors KA; Brooks BW; Rand GM
Rev Environ Contam Toxicol; 2012; 218():1-99. PubMed ID: 22488604
[TBL] [Abstract][Full Text] [Related]
36. A comparison of human pharmaceutical concentrations in raw municipal wastewater and yellowwater.
Winker M; Faika D; Gulyas H; Otterpohl R
Sci Total Environ; 2008 Jul; 399(1-3):96-104. PubMed ID: 18455216
[TBL] [Abstract][Full Text] [Related]
37. Toxic and genotoxic impact of fibrates and their photoproducts on non-target organisms.
Isidori M; Nardelli A; Pascarella L; Rubino M; Parrella A
Environ Int; 2007 Jul; 33(5):635-41. PubMed ID: 17320957
[TBL] [Abstract][Full Text] [Related]
38. Screening and human health risk assessment of pharmaceuticals and their transformation products in Dutch surface waters and drinking water.
de Jongh CM; Kooij PJ; de Voogt P; ter Laak TL
Sci Total Environ; 2012 Jun; 427-428():70-7. PubMed ID: 22551934
[TBL] [Abstract][Full Text] [Related]
39. Colloids as a sink for certain pharmaceuticals in the aquatic environment.
Maskaoui K; Zhou JL
Environ Sci Pollut Res Int; 2010 May; 17(4):898-907. PubMed ID: 20024675
[TBL] [Abstract][Full Text] [Related]
40. Pharmaceutical compounds in the wastewater process stream in Northwest Ohio.
Spongberg AL; Witter JD
Sci Total Environ; 2008 Jul; 397(1-3):148-57. PubMed ID: 18396321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
